Vectura

10 Decision Makers · 13 Verified Contacts & Email Format

📍 Chippenham, Wiltshire, United KingdomHealthcare & Medical🗓 Est. 1997👥 251–500 employees 💰 $50M–$100M

About Vectura

Vectura focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases.

Email Format

{first_name}.{last_name}@vectura.com — 100.0%

sarah.smith@vectura.com

Leadership & Decision Makers

Contact details of 10 Vectura decision makers

Trevor Phillips

COO

Karl Keegan

Chief Corporate Development Officer

Joanne Hombal

Human Resources Director

Sharon Johnson

EVP Delivery Management

Paul Fry

CFO

Elizabeth Knowles (FCA)

Chief Financial Officer

Fraser Smith

Regional Vice President

Nick Angell

Vice President Information Technology

Sharon Eyre

Vice President Finance Operations & Transformation

Matthew Pollard

SVP Operations

Team & Specialists

Contact details of 3 Vectura team members

Begona Carreno

  • Work email

    b************o@vectura.com

First Last

  • Work email

    f********t@vectura.com

Roger Heerman

CCO

General Emails

General company emails, e.g. customer support lines

    info@vectura.com

    General Inquiries

    anne.hyland@vectura.com

    Unclassified inbox

Similar Companies like Vectura

Moderna

modernatx.com
Biotechnology · Cambridge, MA · Est. 2010 · 1001–5000 employees

HQ: Cambridge, MA

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Biotechnology · Boston, MA · Est. 1989 · 1001–5000 employees · $500M–$1B

HQ: Boston, MA

AbbVie

abbvie.com
Biotechnology · North Chicago, Illinois, United States · Est. 2013 · Above 10001 employees

HQ: North Chicago, Illinois, United States

Biotechnology · New York, NY · Est. 1849 · Above 10001 employees

HQ: New York, NY

Explore similar firms in the Healthcare & Medical sector

Company Info

Last updated: 31/07/2025

+4401249667700

Chippenham, Wiltshire, United Kingdom

Acquired by: Philip Morris International
Business Type: Public
Employees: 251-500
Annual Revenue: $50M–$100M
Rounds: Private Equity
Founded Date: 1997
Number of Exits: 1
Company Type: For Profit
Stock Symbol: LSE:VEC
Operating Status: Active
Last Funding Type: Private Equity
Phone Number: +4401249667700
Last Investment Activity: Apr 16, 2024
Investments Activity: Apr 16, 2024 Dec 29, 2021 Oct 11, 2021

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.